PharmaVentures Ltd

What PharmaVentures Ltd does

PharmaVentures Ltd is a privately held UK transaction advisory firm founded in 1992, headquartered in London with operational roots in Oxford. The firm specializes in M&A, licensing, divestments, valuations, and strategic alliance advisory for the pharmaceutical, biotechnology, medtech, CRO/CDMO, and life sciences sectors, having acted on over 1,000 deal-related projects over its 30+ year history. Its client base spans large global pharmaceutical companies (Novartis, Sanofi, MSD/Merck, UCB), mid-market biotechs and CROs, diagnostics firms, medical device companies, and university technology transfer offices.

The firm's core offering is bespoke transaction advisory services, augmented by the proprietary PharmaDeals database (28,000+ deals and alliances records) and PharmaTelevision media platform (200+ programmes reaching a 60% C-suite audience). The team comprises 30+ professionals plus regional associates across the UK, US, South Korea, Australia, and New Zealand, including former senior executives from Goldman Sachs, Sanofi, Bristol-Myers Squibb, Pfizer, GSK, Amgen, and UCB. PharmaVentures Capital Ltd, an FCA-authorized subsidiary, provides regulated corporate advisory services within the group.

Revenue is generated primarily through per-engagement advisory fees negotiated on a project basis reflecting deal complexity, with a secondary recurring stream from PharmaDeals database subscriptions. Distribution is direct via senior advisory professionals, supported by thought-leadership content, industry conference presence (BIO, JPM Week, CPhI Worldwide), and partnerships (e.g., Shinhan Investment Corp MOU in Korea). Recent strategic emphasis is on deepening the Pricing and Market Access practice and expanding M&A advisory capacity through senior leadership additions.

Name

PharmaVentures Ltd

Legal name

PharmaVentures Ltd

Website

https://pharmaventures.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

PharmaVentures Ltd is a UK-based transaction advisory firm specializing in pharmaceutical, biotech, medtech, and life sciences M&A, licensing, divestments, and valuations, with 30+ professionals, 1,000+ deals over 30 years, and offices in the UK, US, South Korea, Australia, and New Zealand.

Ownership category

akta.pro rank

Product category

Pharmaceutical Transaction Advisory

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

Keywords

• Pharmaceutical M&A advisory
• Biotech deal advisory
• Licensing transactions
• Life sciences valuations
• Pricing market access

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Transaction Advisory Services: Advisory fees generated from M&A, licensing, divestments, joint venture, and strategic alliance engagements. Services include strategic advice, full end-to-end process management, deal structuring, due diligence, and valuations for clients ranging from pharmaceutical companies to biotechs, medtech, CROs, CDMOs, and universities.
2. PharmaDeals Database Subscription: Subscription-based access to the PharmaDeals v2 database containing 28,000+ deals and alliances records. Includes PharmaDeals Review online publication, article archive, and PharmaTelevision video content. Offered via IP domain-authenticated access and XML feeds for enterprise customers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels9 records

Core offering

PharmaVentures is a premier transaction advisory firm providing end-to-end M&A, licensing, divestment, valuation, due diligence, strategy, and pricing/market access advisory services to pharmaceutical, biotech, medtech, CRO/CDMO, diagnostics, university, and life sciences clients worldwide. The firm supports 1,000+ deal-related projects over 30+ years using a proprietary PharmaDeals database and a senior network spanning innovators to large pharma. It also operates PharmaTelevision, an industry media platform, and an FCA-authorised advisory subsidiary.

Product overview

PharmaVentures Ltd is a premier transaction advisory firm operating as a services-based consultancy rather than a software product company. The firm offers an integrated suite of advisory services comprising M&A advisory (divestments, mergers, acquisitions, strategic transactions), Licensing (in and out licensing), Strategy (commercialisation, deal strategy, due diligence, market entry), Valuations (for licensing, M&A, and fundraising), Pricing and Market Access, and Due Diligence services. Supporting these core services is the PharmaDeals Database—a proprietary data product containing 28,000+ deals for benchmarking and competitive analysis. The firm also operates PharmaTelevision, a media division offering an online TV channel, production services, conference services, and technical services. Additional content offerings include White Papers, the Termsheet quarterly publication, Podcasts, and PharmaVentures Insights. PharmaVentures Capital Ltd serves as the FCA-authorised subsidiary. The company is headquartered in London with operations in Oxford, and maintains associates across Europe and Asia-Pacific.

Differentiator

Problem solved

Functional benefit

Brands

• PharmaTelevision: Online television channel dedicated to the pharmaceutical and biotech sector, offering daily television news, analysis and feature interviews with industry leaders.
• PharmaDeals

Products and services

• M&A Advisory Services Strategic advice and full end-to-end process management for mergers, acquisitions, divestments, and strategic transactions, from identifying acquisition targets to advising on exit strategy. Targeted at large pharmaceutical companies, biotechs, CROs/CDMOs, and other life sciences clients.
• Licensing Services In and out licensing deal services for top tier pharmaceutical companies, biotechs, diagnostics, medtech, healthcare IT and life science research companies, universities and technology transfer agencies. Covers partner identification, deal structuring, negotiation, and execution.
• Strategy Consulting Actionable strategies developed using internal therapeutic expertise coupled with targeted data analytics to maximise opportunities and mitigate risk for clients. Includes commercialisation, deal strategy, market entry, and commercial/technical due diligence.
• Valuations Asset valuations across therapy areas such as CNS, Ophthalmology, Oncology, GI, and Respiratory diseases, including valuations for contractual disputes and supporting M&A, licensing, and fundraising decisions.
• Pricing and Market Access Pricing and market access strategy services integral to bringing products to market and deal-making, including pricing narrative development and data generation plans. Supports clients in sell-side, buy-side, and licensing due diligence.
• Due Diligence Services Commercial and technical due diligence services supporting transaction processes and investment decision-making, including sell-side, buy-side, and licensing due diligence.
• Fundraising Support Support services for companies seeking fundraising, working alongside M&A, licensing, and valuation capabilities to identify and secure investors.
• PharmaDeals Database Comprehensive database of deals and alliances for the pharmaceuticals sector containing 28,000+ deals, with pharmaceutical product mapping, enhanced product type classification, license territory classification, watch list features, email alerting, and XML feed delivery options. Sold via subscription to enterprise customers.
• PharmaTelevision Online television channel dedicated to the pharmaceutical and biotech sector offering daily television news, analysis, feature interviews, Financial Report, Regional Report, and PTV News daily news summary. 200+ programmes with a 60% C-suite executive audience.
• PharmaTelevision Production Services Production services providing unique ways for companies to communicate to industry stakeholders through professional television production.
• PharmaTelevision Conference Services Conference services for disseminating important communications from business partnering, logistical, and scientific conferences within the pharmaceutical industry.
• PharmaTelevision Technical Services Technical services helping pharma and biotech companies customise and integrate content into existing infrastructure, including rich text transcription, iPhone alerting, and in-video jump-to-chapter features.
• PharmaVentures Capital Ltd (FCA-authorised advisory subsidiary) FCA-authorised and regulated subsidiary (FCA Reference: 741356) providing corporate advisory services within the PharmaVentures group.

Quantifiable outcome

• Advised on over 1,000 deal-related projects over 30+ years
• +3 more outcomes

Named customers20 records

Segments7 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Informa (CPhI Worldwide)minorGTM or Marketing Partner · 1 May 2021PharmaVentures partnered with Informa to deliver a live panel discussion during CPhI Worldwide in the form of a webinar on pharmaceutical contract services consolidation. Chaired by CEO Dr Fintan Walton with panellists from ArrantaBio, Keensight Capital, PharmaLex, and PharmaVentures.
• One NucleusminorStrategic or Co-development PartnerPharmaVentures became a partner of One Nucleus, a UK-based life sciences industry organisation. One Nucleus connects life sciences companies across the UK through networking events, partnering activities, and collaborative initiatives.
• Shinhan Investment CorpcoreStrategic or Co-development PartnerPharmaVentures and Shinhan Investment Corp signed a Memorandum of Understanding to strengthen global collaboration for the Korean biopharma industry. Shinhan Investment Corp is a major Korean financial services firm and PharmaVentures' office in Seoul supports this partnership.
• Growthink ResearchminorStrategic or Co-development PartnerPharmaVentures and Growthink Research joined forces to deliver bioscience industry information solutions, combining PharmaVentures' deal-making expertise and PharmaDeals database with Growthink Research's industry intelligence capabilities.
• Reuters Insider (Cision)minorGTM or Marketing PartnerPharmaTelevision (media division of PharmaVentures) partnered with Reuters Insider to deliver BioPharma Insight to the global financial community, extending the reach of PharmaTelevision's video content to institutional financial audiences.
• Matrix Corporate CapitalminorStrategic or Co-development PartnerMatrix Corporate Capital and PharmaVentures signed a Memorandum of Understanding for collaboration, though specific details of the partnership scope were not disclosed.
• BioCity ScotlandminorOthersPharmaVentures acted as transaction advisor to MSD to secure BioCity Scotland (a joint venture between BioCity Nottingham and Roslin BioCentre) as investor for the former MSD research facility in Newhouse, Lanarkshire, creating an incubator for bioscience companies.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Trinity Partners: Specialist life sciences consulting firm providing strategy, commercial and transaction advisory services to pharma, biotech and medical device companies. Comparable to PharmaVentures in therapeutic-area expertise and advisory scope, with a similarly focused client base.
• RxC International: Specialist pharmaceutical licensing and business development advisory firm supporting in/out licensing, asset valuation and partnering transactions for pharma and biotech clients. Closely comparable in focus on licensing advisory and pharma asset transactions.
• Jefferies Healthcare Group: Healthcare-dedicated investment banking group within Jefferies providing M&A advisory, equity capital markets and financing to pharma, biotech and medtech clients. Closely comparable to PharmaVentures in terms of healthcare-specialist positioning, with significantly broader resources.
• Clairfield International: Global mid-market M&A advisory firm with a dedicated Healthcare and Life Sciences practice advising pharma, biotech and medical device transactions. Comparable as a mid-market M&A advisor serving life sciences clients across Europe and globally.
• Piper Sandler Healthcare: Healthcare-focused investment banking group within Piper Sandler providing M&A advisory and equity capital markets services to pharma, biotech and medtech. Closely aligned with PharmaVentures' specialist advisory model, serving overlapping client segments.
• Alacrita Consulting: Specialist pharma and biotech consulting firm providing commercial, R&D and transaction advisory support to life sciences clients. Directly comparable as a niche pharma/biotech advisory firm of similar scale and specialisation, often operating as a co-advisor on mid-market deals.
• Back Bay Life Science Advisors: Boston-based specialist life sciences advisory firm providing strategic counsel, commercial diligence, valuation and transaction advisory to pharma and biotech clients. Closely comparable as a specialist advisor focused on pharma/biotech transactions and commercial strategy, with similar scale and niche positioning.

Broad incumbents

• Lazard: Global investment bank with a dedicated Healthcare and Life Sciences practice providing M&A advisory, restructuring and capital markets services to pharma, biotech and medtech clients. Directly comparable as a transaction advisor serving the same pharma/biotech client base, though Lazard operates at significantly larger scale and across broader industries.
• Houlihan Lokey: Global investment bank with a strong Healthcare and Life Sciences practice advising on M&A, financings and valuations across pharma, biotech and medical devices. Comparable as a transaction advisor for mid-market pharma/biotech clients, with broader industry coverage and larger deal teams.
• PwC Pharma & Life Sciences Advisory: Big 4 professional services firm with a large pharma and life sciences advisory practice covering M&A, licensing, valuation, pricing/market access and commercial strategy. Competes with PharmaVentures on transaction advisory and pricing/market access mandates, with significantly larger scale and broader service offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/PharmaTVChannel/featured
• LinkedInlinkedin.com/company/pharmaventures
• Xx.com/PharmaVentures
• Facebookfacebook.com/pharmaventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaVentures Ltd